ArticleClinical pharmacology in drug development2026
A Phase 1 Open-Label Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Single Intranasal Dose of Zavegepant in Healthy Chinese Adults.
Qiong Wei et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.